New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 5, 2013
09:12 EDTAFDA approves two Dako assays
Dako, an Agilent Technologies company, announced it has received approval from the FDA for the addition of Kadcyla in the labeling of two Dako companion diagnostic assays. Kadcyla is Genentech's new medicine for patients with HER2-positive metastatic breast cancer who have received prior treatment with Genentech's cancer medicine Herceptin and a taxane chemotherapy. The two assays are Dako's HercepTest and HER2 IQFISH pharmDx.
News For A From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
15:59 EDTAOptions Update; February 4, 2016
Subscribe for More Information
12:55 EDTAAgilent sues Twist, claiming trade secret theft, WSJ reports
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use